177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

NCT05204927 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

439

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastasis From Malignant Tumor of Prostate

Interventions

DRUG: 177Lu-PSMA-I&T
DRUG: Abiraterone with Prednisone or Enzalutamide

Sponsor

Curium US LLC